Q2 2019 Novozymes A/S Earnings Call Transcript
/-&
Good morning, and welcome to the Novozymes conference call. Today, we will review our performance for the first 6 months of 2019 and our outlook and key priorities. Our presentation should take around 25 minutes, and afterwards, we will take your questions. My name is Peder Holk Nielsen, and I'm the CEO of Novozymes. I'm joined here today by the Executive Leadership Team and Investor Relations.
Please turn to Slide #2. Before we jump to the quarterly performance, I'd like to take this opportunity to thank all of you who attended our Capital Markets Day in mid-June. We had more than 100 investors, analysts and journalists at the event and many more joining the webcast. I'm sure you can imagine that it has been a busy period since. We're now in the process of executing on the changes to the business portfolio and on the reallocation program, and I'm happy to say we're making good progress on both.
As you've probably seen this morning, we announced a change in the Executive Leadership
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
